CHARACTERIZATION OF SERA FROM DENGUE INACTIVATED VACCINE PRIMED VOLUNTEERS THAT HAD IMPROVED NEUTRALIZING ANTIBODY RESPONSES AFTER LIVE ATTENUATED DENGUE VACCINE BOOSTING

被引:0
|
作者
Gromowski, Gregory [1 ]
Kuklis, Caitlin [1 ]
Chen, Qiong [1 ]
Barvir, David [1 ]
De La Barrera, Rafael [1 ]
Li, Tao [1 ]
Rutvisuttinunt, Wiriya [1 ]
McCracken, Michael [1 ]
Eckels, Kenneth [1 ]
Lin, Leyi [1 ]
Koren, Michael [1 ]
Jarman, Richard [1 ]
机构
[1] Walter Reed Army Inst Res, Silver Spring, MD USA
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
1613
引用
收藏
页码:508 / 508
页数:1
相关论文
共 50 条
  • [31] The live attenuated dengue serotype 2 vaccine RDEN2 4Δ30 is safe and immunogenic in healthy volunteers
    McArthur, Julie H.
    Marron, Jennifer A.
    Thumar, Bhavin
    Wanionek, Kimberli A.
    Lovchik, Janece M.
    Blaney, Joseph E.
    Murphy, Brian R.
    Whitehead, Stephen S.
    Durbin, Anna P.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (05): : 281 - 282
  • [32] CHARACTERIZATION OF THE NEUTRALIZING ANTIBODY RESPONSE IN BASELINE SERONEGATIVE CHILDREN, ADOLESCENT AND ADULT RECIPIENTS OF A TETRAVALENT DENGUE VACCINE
    Zahralban-Steele, Melissa
    Kaiser, Maima
    Rindfleisch, Tim
    Bohning, Kelly
    Norwood, Brooke
    Dominguez, David
    DeMaso, Christina
    Sharma, Mayuri
    Dean, Hansi
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (05): : 51 - 51
  • [33] An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model
    Putnak, JR
    Coller, BA
    Voss, G
    Vaughn, DW
    Clements, D
    Peters, I
    Bignami, G
    Houng, HS
    Chen, RCM
    Barvir, DA
    Seriwatana, J
    Cayphas, S
    Garçon, N
    Gheysen, D
    Kanesa-thasan, N
    McDonell, M
    Humphreys, T
    Eckels, KH
    Prieels, JP
    Innis, BL
    VACCINE, 2005, 23 (35) : 4442 - 4452
  • [34] IMMUNIZATION WITH A LIVE ATTENUATED DENGUE-2-VIRUS CANDIDATE VACCINE (16681-PDK 53) - CLINICAL, IMMUNOLOGICAL AND BIOLOGICAL RESPONSES IN ADULT VOLUNTEERS
    BHAMARAPRAVATI, N
    YOKSAN, S
    CHAYANIYAYOTHIN, T
    ANGSUBPHAKORN, S
    BUNYARATVEJ, A
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1987, 65 (02) : 189 - 195
  • [35] Structure-guided vaccine design to focus antibody responses to neutralizing epitopes on dengue virus envelope protein
    Thiono, Devina J.
    Samaras, Demetrios
    Phan, Thanh T. N.
    Tian, Shaomin
    Forsberg, Lawrence J.
    Kuhlman, Brian
    de Silva, Aravinda
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [36] A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country
    Tricou, Vianney
    Eyre, Susannah
    Ramjee, Mahadev
    Mojares, Zenaida
    Collini, Paul
    Loeliger, Edde
    Mandaric, Sanja
    Rauschera, Martina
    Brose, Manja
    Lefevre, Inge
    Folschweiller, Nicolas
    Wallace, Derek
    VACCINE, 2023, 41 (07) : 1398 - 1407
  • [37] The live attenuated dengue serotype 1 vaccine rDEN1Δ30 is safe and highly immunogenic in healthy adult volunteers
    Durbin, Anna P.
    McArthur, Julie
    Marron, Jennifer A.
    Blaney, Joseph E., Jr.
    Thumar, Bhavin
    Wanionek, Kim
    Murphy, Brian R.
    Whitehead, Stephen S.
    HUMAN VACCINES, 2006, 2 (04): : 167 - 173
  • [38] Differences in Antibody Responses Between Trivalent Inactivated Influenza Vaccine and Live Attenuated Influenza Vaccine Correlate With the Kinetics and Magnitude of Interferon Signaling in Children
    Cao, Raquel G.
    Suarez, Nicolas M.
    Obermoser, Gerlinde
    Lopez, Santiago M. C.
    Flano, Emilio
    Mertz, Sara E.
    Albrecht, Randy A.
    Garcia-Sastre, Adolfo
    Mejias, Asuncion
    Xu, Hui
    Qin, Huanying
    Blankenship, Derek
    Palucka, Karolina
    Pascual, Virginia
    Ramilo, Octavio
    JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (02): : 224 - 233
  • [39] Short report: Immune response and occurrence of dengue infection in thai children three to eight years after vaccination with live attenuated tetravalent dengue vaccine
    Chanthavanich, Pornthep
    Luxemburger, Christine
    Sirivichayakul, Chukiat
    Lapphra, Keswadee
    Pengsaa, Krisana
    Yoksan, Sutee
    Sabchareon, Arunee
    Lang, Jean
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (01): : 26 - 28
  • [40] Characterization of the Type-Specific and Cross-Reactive B-Cell Responses Elicited by a Live-Attenuated Tetravalent Dengue Vaccine
    Michlmayr, Daniela
    Andrade, Paulina
    Nascimento, Eduardo J. M.
    Parker, Allan
    Narvekar, Parnal
    Dean, Hansi J.
    Harris, Eva
    JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (02): : 247 - 257